JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Osteopenia

Obligatory

Must not donate if:

The donor is being treated with systemic monoclonal antibody therapy e.g. Denosumab (Prolia®). See Monoclonal antibody therapy and other Biological Modalities.

Discretionary

If the cause is not of itself a reason to defer, even if on treatment to prevent or treat (other than Denosumab), accept.

See if Relevant

Disabled Donor
Malignancy
Monoclonal antibody therapy and other Biological Modalities
Steroid Therapy
Vitamins and Other Nutritional Supplements

Additional Information

Osteopenia occurs when there is decreased mineralization (mainly lack of calcium) of bone. It can occur for many reasons so it is important to ensure that it is not associated with a condition that would require a potential donor to be deferred.

Reason for change

The See if Relevant section has been updated.

Donor Information

If you wish to obtain more information regarding a personal medical issue please contact your National Help Line.

Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.

Update Information

This entry was last updated in:
WB-DSG Edition 203 Release 71